Therapeutic significance of targeting survivin in cervical cancer and possibility of combination therapy with TRAIL

Hiroe Nakamura(The University of Tokyo), Tomoyuki Fujii(Tohoku University)
Oncotarget
February 5, 2018
Cited by 29


Related Papers